CN Stock MarketDetailed Quotes

002294 Shenzhen Salubris Pharmaceuticals

Watchlist
  • 28.28
  • +0.30+1.07%
Market Closed Jul 17 15:00 CST
31.53BMarket Cap55.34P/E (TTM)

Shenzhen Salubris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenzhen Salubris Pharmaceuticals Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.09B

+22.92%
EPS(YoY)

0.18

-5.26%
Analyst Rating

Strong Buy

Jul 17, 2024

Shenzhen Salubris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 29, 20192019/Q31.208B / 1.278B--
Aug 27, 20192019/Q21.168B / 1.229B--
Apr 23, 20192019/Q11.189B / 1.229B--
DatePeriodRevenue/EstimateEarnings Call
Oct 29, 20192019/Q31.208B / 1.278B--
Aug 27, 20192019/Q21.168B / 1.229B--
Apr 23, 20192019/Q11.189B / 1.229B--
--------
--------

Unlock Free Earnings Estimates

Shenzhen Salubris Pharmaceuticals Earnings Reports

  • Xinlitai: First Quarter Report 2024

    Apr 22 12:00 ET

  • Xinlitai: Annual Report 2023

    Mar 25 12:00 ET

  • Xinlitai: 2023 Annual Report Summary

    Mar 25 12:00 ET

  • Xinlitai: Report for the third quarter of 2023

    Oct 30, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 17, 2024

    Strong Buy

    • Strong Buy

      85.71%

    • Buy

      14.29%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg